Inhibition of SOX15 Sensitizes Esophageal Squamous Carcinoma Cells to Paclitaxel.

In conclusion, the current study revealed that inhibition of SOX15 in ESCC cells sensitizes the ESCC cells to paclitaxel, suggesting that the SOX15 expression level may predict the therapeutic outcomes for paclitaxel treatment for ESCC.
PMID: 30950353 [PubMed - as supplied by publisher]

Source: Current Molecular Medicine - April 4, 2019 Category: Molecular Biology Authors: Zhang M, Wang J, Gao T, Chen X, Xu Y, Yu X, Guo X, Zhuang R, Li Z, Wu H, Yu J Tags: Curr Mol Med Source Type: research